Takeda Pharmaceutical, a global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide, has joined the Massachusetts Institute of Technology Center for Biomedical Innovation’s New … Read More

NEW MEMBER NEWDIGS welcomes Takeda Pharmaceuticals as a new collaborator in the LEAPS Project Takeda Pharmaceutical, a global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people … Read More

WE’RE GROWING NEWDIGS searching for new director, program manager We’re searching for Director and Program manager talent—join our interdisciplinary think-and-do tank designing solutions to make biopharma and healthcare systems more … Read More

In February 2022, Kay Larholt retired from her role as Director of Research for NEWDIGS, to stay on as a Senior Advisor. Fotios Kokkotos joined as NEWDIGS’ Director of Data … Read More

RECENT PUBLICATION LEAPS research in Precision Reimbursement published in Clinical Pharmacology & Therapeutics The article, “Precision Reimbursement for Precision Medicine: Using Real-World Evidence to Evolve From Trial-and-Project to Track-and-Pay to Learn-and-Predict,” appeared … Read More

DESIGN LAB REPORT LEAPS Design Lab advances pilot projects At the November 30 and December 1 Design Lab participants shaped the designs for three pilots to launch in 2022.   … Read More

NEW MEMBER Flatiron Health joins LEAPS Project This month, Flatiron Health, the clinical and science data healthtech company dedicated to helping cancer centers thrive and deliver better care for patients today … Read More

NEW RESEARCH Precision for whom? Partnering with patients to ensure that Precision Medicine targets what matters Despite decades of growth and adaptation in patient engagement, knowing or being able to … Read More